Increased inhibitory KIR-HLA binding strength has been shown to positively correlate with NK cytotoxicity against HLA-negative target cell lines in vitro [27], and this may exacerbate autoreactivity in instances that HLA expression is downregulated or altered peptides subvert binding in an inflammatory-disease setting. Here, KIR3DL1 is linked to glycogen storage disease VI.